1811 related articles for article (PubMed ID: 31322116)
1. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.
Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Christensen H; Ciccone A; Collins R; Czlonkowska A; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Krishnan K; Laska AC; Law ZK; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Seiffge D; Scutt P; Thanabalan J; Werring D; Whynes D; Bath PM;
Lancet; 2018 May; 391(10135):2107-2115. PubMed ID: 29778325
[TBL] [Abstract][Full Text] [Related]
3. A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT.
Roberts I; Shakur-Still H; Afolabi A; Akere A; Arribas M; Austin E; Bal K; Bazeer N; Beaumont D; Brenner A; Carrington L; Chaudhri R; Coats T; Gilmore I; Halligan K; Hussain I; Jairath V; Javaid K; Kayani A; Lisman T; Mansukhani R; Miners A; Mutti M; Nadeem MA; Pollok R; Prowse D; Simmons J; Stanworth S; Veitch A; Williams J
Health Technol Assess; 2021 Oct; 25(58):1-86. PubMed ID: 34663491
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.
Roberts I; Shakur-Still H; Aeron-Thomas A; Beaumont D; Belli A; Brenner A; Cargill M; Chaudhri R; Douglas N; Frimley L; Gilliam C; Geer A; Jamal Z; Jooma R; Mansukhani R; Miners A; Pott J; Prowse D; Shokunbi T; Williams J
Health Technol Assess; 2021 Apr; 25(26):1-76. PubMed ID: 33928903
[TBL] [Abstract][Full Text] [Related]
5. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
[TBL] [Abstract][Full Text] [Related]
6. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial.
Perel P; Al-Shahi Salman R; Kawahara T; Morris Z; Prieto-Merino D; Roberts I; Sandercock P; Shakur H; Wardlaw J
Health Technol Assess; 2012; 16(13):iii-xii, 1-54. PubMed ID: 22417901
[TBL] [Abstract][Full Text] [Related]
7. Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage.
Eilertsen H; Menon CS; Law ZK; Chen C; Bath PM; Steiner T; Desborough MJ; Sandset EC; Sprigg N; Al-Shahi Salman R
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD005951. PubMed ID: 37870112
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.
Yassi N; Zhao H; Churilov L; Wu TY; Ma H; Nguyen HT; Cheung A; Meretoja A; Mai DT; Kleinig T; Jeng JS; Choi PMC; Duc PD; Brown H; Ranta A; Spratt N; Cloud GC; Wang HK; Grimley R; Mahawish K; Cho DY; Shah D; Nguyen TMP; Sharma G; Yogendrakumar V; Yan B; Harrison EL; Devlin M; Cordato D; Martinez-Majander N; Strbian D; Thijs V; Sanders LM; Anderson D; Parsons MW; Campbell BCV; Donnan GA; Davis SM;
Lancet Neurol; 2024 Jun; 23(6):577-587. PubMed ID: 38648814
[TBL] [Abstract][Full Text] [Related]
9. Effect of Tranexamic Acid Administration on Remote Cerebral Ischemic Lesions in Acute Spontaneous Intracerebral Hemorrhage: A Substudy of a Randomized Clinical Trial.
Pszczolkowski S; Sprigg N; Woodhouse LJ; Gallagher R; Swienton D; Law ZK; Casado AM; Roberts I; Werring DJ; Al-Shahi Salman R; England TJ; Morgan PS; Bath PM; Dineen RA
JAMA Neurol; 2022 May; 79(5):468-477. PubMed ID: 35311937
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial.
Meretoja A; Yassi N; Wu TY; Churilov L; Sibolt G; Jeng JS; Kleinig T; Spratt NJ; Thijs V; Wijeratne T; Cho DY; Shah D; Cloud GC; Phan T; Bladin C; Moey A; Aviv RI; Barras CD; Sharma G; Hsu CY; Ma H; Campbell BCV; Mitchell P; Yan B; Parsons MW; Tiainen M; Curtze S; Strbian D; Tang SC; Harvey J; Levi C; Donnan GA; Davis SM
Lancet Neurol; 2020 Dec; 19(12):980-987. PubMed ID: 33128912
[TBL] [Abstract][Full Text] [Related]
11. Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trial.
Sprigg N; Robson K; Bath P; Dineen R; Roberts I; Robinson T; Roffe C; Werring D; Al-Shahi Salman R; Pocock S; Duley L; England T; Whynes D; Ciccone A; Laska AC; Christensen H; Ozturk S; Collins R; Bereczki D; Egea-Guerrero JJ; Law ZK; Czlonkowska A; Seiffge D; Beredzie M;
Int J Stroke; 2016 Aug; 11(6):683-94. PubMed ID: 27048694
[TBL] [Abstract][Full Text] [Related]
12. Statistical analysis plan for the 'Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage' (TICH-2) trial.
Flaherty K; Bath PM; Dineen R; Law Z; Scutt P; Pocock S; Sprigg N;
Trials; 2017 Dec; 18(1):607. PubMed ID: 29262841
[TBL] [Abstract][Full Text] [Related]
13. The spot sign and tranexamic acid on preventing ICH growth--AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial.
Meretoja A; Churilov L; Campbell BC; Aviv RI; Yassi N; Barras C; Mitchell P; Yan B; Nandurkar H; Bladin C; Wijeratne T; Spratt NJ; Jannes J; Sturm J; Rupasinghe J; Zavala J; Lee A; Kleinig T; Markus R; Delcourt C; Mahant N; Parsons MW; Levi C; Anderson CS; Donnan GA; Davis SM
Int J Stroke; 2014 Jun; 9(4):519-24. PubMed ID: 23981692
[TBL] [Abstract][Full Text] [Related]
14. Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCT.
Dennis M; Forbes J; Graham C; Hackett M; Hankey GJ; House A; Lewis S; Lundström E; Sandercock P; Mead G
Health Technol Assess; 2020 May; 24(22):1-94. PubMed ID: 32452356
[TBL] [Abstract][Full Text] [Related]
15. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.
HALT-IT Trial Collaborators
Lancet; 2020 Jun; 395(10241):1927-1936. PubMed ID: 32563378
[TBL] [Abstract][Full Text] [Related]
16. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.
WOMAN Trial Collaborators
Lancet; 2017 May; 389(10084):2105-2116. PubMed ID: 28456509
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in Antiplatelet-Associated Intracerebral Hemorrhage in the TICH-2 Randomized Controlled Trial.
Law ZK; Desborough M; Roberts I; Al-Shahi Salman R; England TJ; Werring DJ; Robinson T; Krishnan K; Dineen R; Laska AC; Peters N; Egea-Guerrero JJ; Karlinski M; Christensen H; Roffe C; Bereczki D; Ozturk S; Thanabalan J; Collins R; Beridze M; Bath PM; Sprigg N
J Am Heart Assoc; 2021 Feb; 10(5):e019130. PubMed ID: 33586453
[TBL] [Abstract][Full Text] [Related]
18. Surgical Trial In Traumatic intraCerebral Haemorrhage (STITCH): a randomised controlled trial of Early Surgery compared with Initial Conservative Treatment.
Gregson BA; Rowan EN; Francis R; McNamee P; Boyers D; Mitchell P; McColl E; Chambers IR; Unterberg A; Mendelow AD;
Health Technol Assess; 2015 Sep; 19(70):1-138. PubMed ID: 26346805
[TBL] [Abstract][Full Text] [Related]
19. Does tranexamic acid lead to changes in MRI measures of brain tissue health in patients with spontaneous intracerebral haemorrhage? Protocol for a MRI substudy nested within the double-blind randomised controlled TICH-2 trial.
Dineen RA; Pszczolkowski S; Flaherty K; Law ZK; Morgan PS; Roberts I; Werring DJ; Al-Shahi Salman R; England T; Bath PM; Sprigg N
BMJ Open; 2018 Feb; 8(2):e019930. PubMed ID: 29431141
[TBL] [Abstract][Full Text] [Related]
20. Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trial.
Yassi N; Zhao H; Churilov L; Campbell BCV; Wu T; Ma H; Cheung A; Kleinig T; Brown H; Choi P; Jeng JS; Ranta A; Wang HK; Cloud GC; Grimley R; Shah D; Spratt N; Cho DY; Mahawish K; Sanders L; Worthington J; Clissold B; Meretoja A; Yogendrakumar V; Ton MD; Dang DP; Phuong NTM; Nguyen HT; Hsu CY; Sharma G; Mitchell PJ; Yan B; Parsons MW; Levi C; Donnan GA; Davis SM
Stroke Vasc Neurol; 2022 Apr; 7(2):158-165. PubMed ID: 34848566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
